Company Filing History:
Years Active: 2017
Title: Hermiena Christina Schoterman: Innovator in Mycotoxin Treatment
Introduction
Hermiena Christina Schoterman is a notable inventor based in Zutphen, Netherlands. She has made significant contributions to the field of health and nutrition, particularly in the treatment of conditions associated with mycotoxin exposure. Her innovative work has led to the development of a patented composition that addresses these health concerns.
Latest Patents
Hermiena holds a patent for the "Treatment of conditions associated with mycotoxin exposure." This patent describes a composition comprising a non-digestible oligosaccharide aimed at the treatment, prevention, or alleviation of conditions related to trichothecene mycotoxin exposure. The composition may include galactooligosaccharides and/or fructooligosaccharides, specifically short chain galacto-oligosaccharides (scGOS) and/or short chain fructooligosaccharides (scFOS). The conditions addressed by this patent are particularly associated with exposure to deoxynivalenol.
Career Highlights
Hermiena is affiliated with N.V. Nutricia, a company known for its focus on nutritional products. Her work at Nutricia has allowed her to explore innovative solutions to health issues, particularly those related to mycotoxins.
Collaborations
Throughout her career, Hermiena has collaborated with esteemed colleagues such as Johan Garssen and Johanna Fink-Gremmels. These collaborations have further enriched her research and development efforts in the field of nutrition and health.
Conclusion
Hermiena Christina Schoterman is a pioneering inventor whose work in mycotoxin treatment showcases her commitment to improving health outcomes. Her innovative patent and collaborations highlight her significant contributions to the field of nutrition.